Hänggi, D., & Etminan, N. (2019). Clinical trial protocol: Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group, efficacy, and safety study comparing EG-1962 to standard of care oral nimodipine in adults with aneurysmal subarachnoid hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)]. Neurocritical care, 30(1), . https://doi.org/10.1007/s12028-018-0575-z
Chicago-Zitierstil (17. Ausg.)Hänggi, Daniel, und Nima Etminan. "Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)]." Neurocritical Care 30, no. 1 (2019). https://doi.org/10.1007/s12028-018-0575-z.
MLA-Zitierstil (9. Ausg.)Hänggi, Daniel, und Nima Etminan. "Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)]." Neurocritical Care, vol. 30, no. 1, 2019, https://doi.org/10.1007/s12028-018-0575-z.